Georgios Tsivgoulis1, Aristeidis H Katsanos2, Peter D Schellinger2, Martin Köhrmann2, Panayiotis Varelas2, Georgios Magoufis2, Maurizio Paciaroni2, Valeria Caso2, Anne W Alexandrov2, Edip Gurol2, Andrei V Alexandrov2. 1. From the Second Department of Neurology, Attikon University Hospital, National and Kapodistrian University of Athens, Greece (G.T., A.H.K.); Department of Neurology, University of Tennessee Health Science Center, Memphis (G.T., A.W.A., A.V.A.); Department of Neurology, University of Ioannina, Greece (A.H.K.); Department of Neurology (P.D.S.) and Department of Neurogeriatry (P.D.S.), Johannes Wesling Medical Center, Ruhr University Bochum, Minden, Germany; Department of Neurology, Universitätsklinikum Essen, Germany (M.K.); Department of Neurology, Henry Ford Hospital, Detroit, MI (P.V.); Department of Interventional Neuroradiology, Metropolitan Hospital, Piraeus, Greece (G.M.); Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Italy (M.P., V.C.); and J.P. Kistler Stroke Research Center, Massachusetts General Hospital, Boston (E.G.). tsivgoulisgiorg@yahoo.gr. 2. From the Second Department of Neurology, Attikon University Hospital, National and Kapodistrian University of Athens, Greece (G.T., A.H.K.); Department of Neurology, University of Tennessee Health Science Center, Memphis (G.T., A.W.A., A.V.A.); Department of Neurology, University of Ioannina, Greece (A.H.K.); Department of Neurology (P.D.S.) and Department of Neurogeriatry (P.D.S.), Johannes Wesling Medical Center, Ruhr University Bochum, Minden, Germany; Department of Neurology, Universitätsklinikum Essen, Germany (M.K.); Department of Neurology, Henry Ford Hospital, Detroit, MI (P.V.); Department of Interventional Neuroradiology, Metropolitan Hospital, Piraeus, Greece (G.M.); Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Italy (M.P., V.C.); and J.P. Kistler Stroke Research Center, Massachusetts General Hospital, Boston (E.G.).
Abstract
BACKGROUND AND PURPOSE: Although current guidelines advocate pretreatment with intravenous thrombolysis (IVT) in all eligible patients with acute ischemic stroke with large-vessel occlusion before mechanical thrombectomy, there are observational data questioning the efficacy of this approach. One of the main arguments in favor of IVT pretreatment is the potential for tissue-type plasminogen activator-induced successful reperfusion (SR) before the onset of endovascular procedure. METHODS: We performed a systematic review and meta-analysis of randomized controlled clinical trials and observational cohorts providing rates of SR with IVT in patients with large-vessel occlusion before the initiation of mechanical thrombectomy. We also performed subgroup analyses according to study type (randomized controlled clinical trials versus observational) and according to the inclusion per protocol of patients with tandem (intracranial/extracranial) occlusions. RESULTS: We identified 13 eligible studies (7 randomized controlled clinical trials and 6 observational cohorts), including 1561 patients with acute ischemic stroke (median National Institutes of Health Stroke Scale score, 17) with large-vessel occlusion. SR following IVT and before mechanical thrombectomy was documented in 11% (95% confidence interval, 7%-16%), with no difference among cohorts derived from randomized controlled clinical trials and observational studies. There was significant heterogeneity across included studies both in the overall analysis and among subgroups (I2>84%; P for Cochran Q, <0.001). Higher tissue-type plasminogen activator-induced SR rates were documented in studies reporting the exclusion of tandem occlusions (17%; 95% confidence interval, 11%-23%) compared with the rest (7%; 95% confidence interval, 4%-11%; P for subgroup differences, 0.003). CONCLUSIONS: Pretreatment with systemic thrombolysis in patients with large-vessel occlusion eligible for mechanical thrombectomy results in SR in 1 of 10 cases, negating the need for additional endovascular reperfusion. Tandem occlusions seem to be the least responsive to IVT pretreatment.
BACKGROUND AND PURPOSE: Although current guidelines advocate pretreatment with intravenous thrombolysis (IVT) in all eligible patients with acute ischemic stroke with large-vessel occlusion before mechanical thrombectomy, there are observational data questioning the efficacy of this approach. One of the main arguments in favor of IVT pretreatment is the potential for tissue-type plasminogen activator-induced successful reperfusion (SR) before the onset of endovascular procedure. METHODS: We performed a systematic review and meta-analysis of randomized controlled clinical trials and observational cohorts providing rates of SR with IVT in patients with large-vessel occlusion before the initiation of mechanical thrombectomy. We also performed subgroup analyses according to study type (randomized controlled clinical trials versus observational) and according to the inclusion per protocol of patients with tandem (intracranial/extracranial) occlusions. RESULTS: We identified 13 eligible studies (7 randomized controlled clinical trials and 6 observational cohorts), including 1561 patients with acute ischemic stroke (median National Institutes of Health Stroke Scale score, 17) with large-vessel occlusion. SR following IVT and before mechanical thrombectomy was documented in 11% (95% confidence interval, 7%-16%), with no difference among cohorts derived from randomized controlled clinical trials and observational studies. There was significant heterogeneity across included studies both in the overall analysis and among subgroups (I2>84%; P for Cochran Q, <0.001). Higher tissue-type plasminogen activator-induced SR rates were documented in studies reporting the exclusion of tandem occlusions (17%; 95% confidence interval, 11%-23%) compared with the rest (7%; 95% confidence interval, 4%-11%; P for subgroup differences, 0.003). CONCLUSIONS: Pretreatment with systemic thrombolysis in patients with large-vessel occlusion eligible for mechanical thrombectomy results in SR in 1 of 10 cases, negating the need for additional endovascular reperfusion. Tandem occlusions seem to be the least responsive to IVT pretreatment.
Authors: Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher Journal: J Clin Epidemiol Date: 2009-07-23 Impact factor: 6.437
Authors: O O Zaidat; M A Lazzaro; D S Liebeskind; N Janjua; L Wechsler; R G Nogueira; R C Edgell; J S Kalia; A Badruddin; J English; D Yavagal; J F Kirmani; A V Alexandrov; P Khatri Journal: Neurology Date: 2012-09-25 Impact factor: 9.910
Authors: Georgios Tsivgoulis; Aristeidis H Katsanos; Dimitris Mavridis; Anne W Alexandrov; Georgios Magoufis; Adam Arthur; Valeria Caso; Peter D Schellinger; Andrei V Alexandrov Journal: Ther Adv Neurol Disord Date: 2016-12-01 Impact factor: 6.570
Authors: Marta Rubiera; Marc Ribo; Raquel Delgado-Mederos; Esteban Santamarina; Pilar Delgado; Joan Montaner; José Alvarez-Sabín; Carlos A Molina Journal: Stroke Date: 2006-08-03 Impact factor: 7.914
Authors: Eva A Mistry; Akshitkumar M Mistry; Mohammad Obadah Nakawah; Rohan V Chitale; Robert F James; John J Volpi; Matthew R Fusco Journal: Stroke Date: 2017-07-26 Impact factor: 7.914
Authors: Maher Saqqur; Ken Uchino; Andrew M Demchuk; Carlos A Molina; Zsolt Garami; Sergio Calleja; Naveed Akhtar; Finton O Orouk; Abdul Salam; Ashfaq Shuaib; Andrei V Alexandrov Journal: Stroke Date: 2007-02-08 Impact factor: 7.914
Authors: Carmen Serna Candel; Marta Aguilar Pérez; Victoria Hellstern; Muhammad AlMatter; Hansjörg Bäzner; Hans Henkes Journal: Cerebrovasc Dis Date: 2019-11-20 Impact factor: 2.762
Authors: Guillaume Turc; Georgios Tsivgoulis; Heinrich J Audebert; Hieronymus Boogaarts; Pervinder Bhogal; Gian Marco De Marchis; Ana Catarina Fonseca; Pooja Khatri; Mikaël Mazighi; Natalia Pérez de la Ossa; Peter D Schellinger; Daniel Strbian; Danilo Toni; Philip White; William Whiteley; Andrea Zini; Wim van Zwam; Jens Fiehler Journal: Eur Stroke J Date: 2022-02-17
Authors: M A Almekhlafi; W G Kunz; B K Menon; R A McTaggart; M V Jayaraman; B W Baxter; D Heck; D Frei; C P Derdeyn; T Takagi; A H Aamodt; I M R Fragata; M D Hill; A M Demchuk; M Goyal Journal: AJNR Am J Neuroradiol Date: 2019-01-31 Impact factor: 3.825
Authors: Vincent A LaBarbera; Aidan Azher; Mahesh V Jayaraman; Linda C Wendell; Daniel C Sacchetti; Bradford Thompson Journal: Neurohospitalist Date: 2020-12-04